Skip to main content
OpenTrials

Clinical trial condition

Neoplasms, Neuroepithelial

Explore clinical trials studying Neoplasms, Neuroepithelial. Study availability and eligibility vary by location and protocol.

2,958 public trials 648 recruiting studies
Refine in advanced search Browse all conditions

Neoplasms, Neuroepithelial trial results

Completed

GDC-0449 in Treating Patients With Recurrent Glioblastoma Multiforme That Can Be Removed by Surgery

NCT00980343

Conditions
Adult Giant Cell Glioblastoma, Adult Glioblastoma, Adult Gliosarcoma, +19 more
Locations
  • University of California at Los Angeles Los Angeles, California, United States
  • University of California San Francisco San Francisco, California, United States
  • Emory University/Winship Cancer Institute Atlanta, Georgia, United States
  • Dana-Farber Cancer Institute Boston, Massachusetts, United States
View Trial Details
Completed

BIBW 2992 (Afatinib) With or Without Daily Temozolomide in the Treatment of Patients With Recurrent Malignant Glioma

NCT00727506

Conditions
Glioma, Neoplasms, Neoplasms by Histologic Type, +5 more
Locations
  • 1200.36.0016 Boehringer Ingelheim Investigational Site Birmingham, Alabama, United States
  • 1200.36.0012 Boehringer Ingelheim Investigational Site Phoenix, Arizona, United States
  • 1200.36.0005 Boehringer Ingelheim Investigational Site Duarte, California, United States
  • 1200.36.0014 Boehringer Ingelheim Investigational Site Los Angeles, California, United States
View all 28 locations
View Trial Details
Completed

A Phase II Study of Oral LDE225 in Patients With Hedge-Hog (Hh)-Pathway Activated Relapsed Medulloblastoma (MB)

NCT01708174

Conditions
Disease Attributes, Glioma, Medulloblastoma, +11 more
Locations
  • Ann & Robert H. Lurie Children Dept of Oncology Chicago, Illinois, United States
  • Sidney Kimmel Comprehensive Cancer Center/Johns Hopkins Med. Dept Onc Baltimore, Maryland, United States
  • Dana Farber Cancer Institute SC-7 Boston, Massachusetts, United States
  • Columbia University Medical Center- New York Presbyterian Dept of Oncology New York, United States
View all 41 locations
View Trial Details
Completed

Gossypol in Treating Patients With Progressive or Recurrent Glioblastoma Multiforme

NCT00540722

Conditions
Adult Giant Cell Glioblastoma, Adult Glioblastoma, Adult Gliosarcoma, +19 more
Locations
  • University of Alabama at Birmingham Birmingham, Alabama, United States
  • Moffitt Cancer Center Tampa, Florida, United States
  • Johns Hopkins University Baltimore, Maryland, United States
  • Massachusetts General Hospital Boston, Massachusetts, United States
View Trial Details
Completed

Doxepin Hydrochloride in Treating Oral Mucositis Pain in Patients With Head and Neck Cancer Undergoing Radiation Therapy With or Without Chemotherapy

NCT01156142

Conditions
Carcinoma, Carcinoma, Squamous Cell, Cranial Nerve Diseases, +33 more
Locations
  • Mayo Clinic Scottsdale Scottsdale, Arizona, United States
  • Saint Francis/Mount Sinai Regional Cancer Center at Saint Francis Hospital and Medical Center Hartford, Connecticut, United States
  • Mayo Clinic - Jacksonville Jacksonville, Florida, United States
  • MBCCOP - Medical College of Georgia Cancer Center Augusta, Georgia, United States
View all 120 locations
View Trial Details
Completed

p28 in Treating Younger Patients With Recurrent or Progressive Central Nervous System Tumors

NCT01975116

Conditions
Anaplastic Astrocytoma, Anaplastic Oligodendroglioma, Astrocytoma, +28 more
Locations
  • Children's Hospital Los Angeles Los Angeles, California, United States
  • Lucile Packard Children's Hospital Stanford University Palo Alto, California, United States
  • Children's National Medical Center Washington D.C., District of Columbia, United States
  • Lurie Children's Hospital-Chicago Chicago, Illinois, United States
View Trial Details
Completed

Erlotinib Compared With Temozolomide or Carmustine in Treating Patients With Recurrent Glioblastoma Multiforme

NCT00086879

Conditions
Astrocytoma, Brain Diseases, Brain Neoplasms, +16 more
Locations
  • U.Z. Gasthuisberg Leuven, Belgium
  • Centre de Lutte Contre le Cancer Georges-Francois Leclerc Dijon, France
  • Centre Regional Rene Gauducheau Nantes-Saint Herblain, France
  • Centre Antoine Lacassagne Nice, France
View Trial Details
Completed

Safety and Efficacy of Trans Sodium Crocetinate (TSC) With Radiation and Temozolomide in Newly Diagnosed Glioblastoma

NCT01465347

Conditions
Astrocytoma, Brain Diseases, Brain Neoplasms, +15 more
Locations
  • St. Joseph's Medical Center Barrow Neurology Clinics Phoenix, Arizona, United States
  • University of Arkansas Winthrop P. Rockefeller Cancer Institute Little Rock, Arkansas, United States
  • USC/Norris Comprehensive Cancer Center Los Angeles, California, United States
  • Cedars-Sinai Medical Center Los Angeles, California, United States
View all 18 locations
View Trial Details

Related conditions